Form 4: Clorox Director Christopher J. Williams Reports Acquisition of Common Stock and Deferred Stock Units

Director Christopher J. Williams reports acquiring common stock in lieu of director's fees and deferred stock units through dividend reinvestment.

Summary

• Christopher J. Williams, a director of Clorox, filed a Form 4 detailing changes in beneficial ownership.
• On September 30, 2024, Williams acquired 199 shares of Clorox common stock at $162.91 per share in lieu of a quarterly director's fee, bringing his total direct holdings to 649 shares.
• On August 30, 2024, Williams acquired 131.0006 Deferred Stock Units through dividend reinvestment, bringing his total to 17,129.941.
• These Deferred Stock Units will be settled in Clorox stock upon his retirement or termination of service as a director.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock acquisition by a director, which can be seen as a positive sign, but it's not a major event.

Positives

• The acquisition of stock by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The Deferred Stock Units will be settled 100% in Clorox stock upon the reporting person's retirement or other termination of service as a Director.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors for signals about management's view of the company's prospects.

Related Party Transactions

• The receipt of common stock in lieu of a quarterly director's fee is a related party transaction.

Stakeholder Impact

• The acquisition of stock by a director can have a minor positive impact on shareholder confidence.

Key Dates